West Virginia University Logo

May 14, 2014


SAMHSA Prescription Drug Abuse Weekly Update
Issue 71  |  May 14, 2014
The Prevention of Prescription Drug Abuse in the Workplace (PAW) TA Center addresses prescription drug abuse—a growing public health problem with increasing burdens on workers, workplaces, and our economy. To subscribe colleagues, family members, or friends to this listserv sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), please click here or send their e-mail addresses to paw@dsgonline.com.
Table of Content Featured Article Journal Articles and Reports Professional Education & Editorial News Other State and Local News Other Resources Grant Announcement Grant Awarded Take-Back Events Save the Date Upcoming Conferences and Workshops


Acupuncture Helping Reduce Use of Pain Killers
May 5, 2014

Brig. Gen. Norvell V. Coots, deputy commanding general of the U.S. Army Medical Command and assistant surgeon general for force projection, told the Senate Veterans Affairs Committee that acupuncture, yoga, and other forms of alternative and complementary medicine are helping reduce use of opioids to block pain in Army patients. In 2011, 26 percent of all service members were prescribed at least one type of opioid medication. That number declined to 24 percent in 2013.Undersecretary for Health (Department of Veterans Affairs) Robert Petzel testified that the VA has added chiropractic care, massages, mindfulness meditation, exercise therapy, and relaxation therapies to its treatment plan for pain.

Read more:

Journal Articles and Reports

Odilon Salim Costa Abrahin, Evitom Corrêa de Sousa, and Azenildo Moura Santos. 2014. "Prevalence of the Use of Anabolic-Androgenic Steroids in Brazil: A Systematic Review." Substance Use and Misuse, doi:10.3109/10826084.2014.903750.

This systematic review evaluated the prevalence of anabolic–androgenic steroid use by practitioners of recreational physical activity in Brazil. Usage varied between 2.1 percent and 31.6 percent, according to the region analyzed and the sample characteristics.

Read more:

Judith S. Brook, Elinor B. Balka, Chenshu Zhang, and David W. Brook. 2014. "ADHD, Conduct Disorder, Substance Use Disorder, and Nonprescription Stimulant Use." Journal of Attention Disorders, doi:10.1177/1087054714528535.

This study examined factors influencing adult use of nonprescription stimulants (e.g., Dexatrim, No-Doz). It analyzed longitudinal data from a representative sample of youths in two upstate New York counties who were surveyed in 1983, 1985–86, 1997, and 2002, with their mothers also polled in the first two surveys. Stimulant use in 2002 was significantly more likely among those diagnosed as ADHD in adolescence, and to a lesser extent among those without ADHD diagnoses who had conduct disorders in adolescence or abused drugs as adults. A structural equation model accounted for the increased odds of conduct disorder and substance abuse among those with ADHD.

Read more:

Lesly–Marie Buer, Jennifer R. Havens, and Carl G. Leukefeld. 2014. "Does the New Formulation of Oxycontin Deter Misuse? A Qualitative Analysis." Substance Use and Misuse 49(6):770–74, doi:10.3109/10826084.2013.866963.

Twenty-five qualitative interviews with rural Appalachians revealed that, when a tamper-resistant formulation of Oxycontin was released, most addicts switched to a short-acting immediate-release formulation.

Read more:

Shan–Estelle Brown and Frederick L. Altice. 2014. "Self-Management of Buprenorphine/Naloxone Among Online Discussion Board Users." Substance Use and Misuse 49(8):1017–24, doi:10.3109/10826084.2014.888449).

To identify facilitators of self-treatment by buprenorphine/naloxone users, researchers analyzed 121 threads posted on 13 discussion boards from September 2010 to November 2012. Facilitators included 1) a ready supply of buprenorphine/naloxone, 2) distrust of buprenorphine prescribers and pharmaceutical companies, 3) the declaration that buprenorphine/naloxone is a "bad tasting" medicine, 4) the desire to adopt a different delivery method other than sublingually, and 5) a desire to become completely "substance free." The sublingual film formulation appears to be an important facilitator in self-treatment, because it can more easily be apportioned to extend the medication owing to limited supply, cost, and tapering. The findings indicate a range of self-management activities ranging from altering the amount taken to modifying the physical medication composition or changing the administration route. Some of these behaviors constitute problematic extramedical use. Contributors to discussion boards seem to trust one another more than they trust pharmacists and prescribing physicians.

Read more:

B.M. Conn and A.K. Marks. 2014. "Ethnic/Racial Differences in Peer and Parent Influence on Adolescent Prescription Drug Misuse." Journal of Developmental Behavioral and Pediatrics 35(4):257–65, doi: 10.1097/DBP.0000000000000058.

Among youths 12 to 17 years old, the 2010 National Survey of Drug Use and Health found that 10.4 percent misused prescription drugs, with white youths most likely to misuse and African American youths least likely. Perceived parental and peer substance use disapproval decreased the likelihood of prescription drug misuse, especially among whites.

Read more:

Ali Eskandar, Feras Mahdi, and Rajeesh Punnakkattu. 2014. "Respiratory Failure Secondary to Drug Overdose Causes and Demographics." American Journal of Respiratory Critical Care Medicine 189:A1625.

Researchers reviewed charts of patients admitted to Casa Grande medical center because of intentional or unintentional drug poisoning during 2009–11. Of 483 patients admitted for drug poisoning, 80 (16.6 percent) were complicated by respiratory failure, with 1 case fatal. Among patients with respiratory failure, more females (33/43, 76.7 percent) than males (22/37, 59.4 percent) had taken multiple drugs. The drugs most often used in the 55 multidrug cases were benzodiazepines in 35, opiates in 18, alcohol in 16, muscle relaxants in 12, antidepressants in 12, and anticonvulsants in 10. Of 25 cases involving just one drug, opiates, muscle relaxants, and benzodiazepines each were responsible for 6 cases.

Read more:

Andrew Gallucci, Ryan Martin, Alex Beaujean, and Stuart Usdan. 2014. "An Examination of the Misuse of Prescription Stimulants Among College Students Using the Theory of Planned Behavior." Psychology, Health & Medicine, doi:10.1080/13548506.2014.913800.

During 2010, 978 students at a large public university in the southeastern United States (67.8 percent female and 82.9 percent white) completed an online survey assessing misuse of prescription stimulants in the past 30 days and misuse-related theory of planned behavior constructs (attitudes, subjective norms, and perceived behavioral control). Multivariate logistic regression indicated that perceived behavioral control increased misuse of prescription stimulants. Students taking a prescribed stimulant were less likely to misuse stimulants.

Read more:

Jessica M. Irvine, Sara E. Hallvik, Christi Hildebran, Miguel Marino, Todd Beran, and Richard A. Deyo. 2014. "Who Uses a Prescription Drug Monitoring Program and How? Insights From a Statewide Survey of Oregon Clinicians." Journal of Pain, doi:10.1016/j.jpain.2014.04.003.

Researchers surveyed a random sample of Oregon providers, with 1,065 respondents. Most prescription drug monitoring program (PDMP) registrants were clinicians in emergency medicine, primary care, or pain and addiction specialties. Many frequent prescribers of controlled substances were not registered users. Among users, 95 percent reported accessing the PDMP when they suspected a patient of abuse or diversion, but fewer than half checked it for every new patient or every time they prescribed a controlled drug. Nearly all users reported that they discuss worrisome PDMP data with patients; 54 percent reported making mental health or substance abuse referrals, and 36 percent reported sometimes discharging patients from the practice. Clinicians reported frequent patient denial or anger, and only occasional requests for help with drug dependence.

Read more:

Elizabeth E. Krans and Shannon L. Dunn. 2014. "Health Care Use Patterns of Opioid-Dependent Pregnant Women." Obstetrics & Gynecology, doi: 10.1097/01.AOG.0000447364.47611.7d.

This study describes healthcare use patterns of opioid-dependent pregnant women and the effect of these patterns on maternal and neonatal outcomes. Researchers retrospectively studied the 174 opioid-dependent pregnant women treated at the University of Pittsburgh between 2009 and 2012 and used propensity scores to select pregnant women not dependent on opioids as controls. Opioid-dependent pregnant women were at a significantly greater gestational age at their first prenatal care visit (16 versus 11 weeks of gestation; P<.01) and significantly less likely to attend prenatal care visits (7.4 versus 11.1 visits; P<.01) and a recommended postpartum visit (24.7 percent versus 42.5 percent). Opioid-dependent pregnant women were also significantly more likely to smoke tobacco (86.1 percent compared with 30.5 percent), use marijuana (20.3 percent compared with 1.2 percent) and cocaine (24.4 percent compared with 0 percent), and receive social work services during pregnancy (96.9 percent compared with 45.9 percent). Neonates of opioid-dependent pregnant women were more likely to be low birth weight (less than 2,500 g; 23.6 percent compared with 10.3 percent), have a prolonged inpatient length of stay at birth (greater than 3 days; 96.1 percent compared with 8.1 percent), a neonatal intensive care unit admission (77.3 percent compared with 14.9 percent), and a hospital readmission after discharge (51.2 percent compared with 8.1 percent).

Read more:

Doctors Have 'Knowledge Gaps' About Opioid Abuse
May 6, 2014

At the American Pain Society 33rd Annual Scientific Meeting, Dr. Joseph Pergolizzi and colleagues reported on a survey of 123 U.S. healthcare providers fielded at a continuing medical education conference (PAINWeek 2013). Most respondents knew about abuse deterrent formulations (ADFs) for patients at risk of opioid abuse, but only 45 percent were aware that 71 percent of prescription opioid misusers report they obtained the drugs from a friend or a relative. Only 53 percent believed that more than half of recreational abuse is sourced through diversion of a legitimate prescription. Among respondents, 43 percent reported that crush resistance was the best abuse-deterrent technology; 8 percent preferred sequestered antagonists. Most respondents (80 percent) did not know that diversion rates of extended-release oxycodone decreased by 60 percent after the switch to ADF. Sixty-three percent were concerned about legal liability if ADFs were available but not prescribed. Respondents said live lectures and mandatory training for licensure were the best ways to educate providers about prescription drug abuse.

Read more:

Matthew Lozier, Colleen Martin, and Daniel Chaput. 2014. "Surveillance of Overdose-Related Emergency Department Visits in Rhode Island." Journal of Public Health Informatics 6(1), doi: 10.5210/ojphi.v6i1.5173.

Researchers determined whether the Rhode Island Real-Time Outbreak and Disease Surveillance system identified an increase in emergency department overdose visits during a known cluster of overdose deaths. Only one emergency department experienced a surge.

Read more:

Ellen LeVonne Parker. 2014. "Connecting the Supply and Need for Buprenorphine Treatment in Kentucky Counties." University of Kentucky. Theses and Dissertations—Public Health (MPH and Dr.P.H.). Paper 9.

Treatment needs measured by calculating opioid overdose hospitalization rates by county from 2008 through 2012 suggest that the greatest needs are in eastern Kentucky and a small pocket of northern Kentucky. The Substance Abuse and Mental Health Services Administration online treatment locator indicates that 46 percent of Kentucky counties (n=56) have at least one licensed buprenorphine physician and eight house community treatment centers prescribing buprenorphine. The treatment need exceeds the supply of physicians and treatment centers.

Read more:

Henrique Marcelo Gualberto Pereira and Vinícius Figueiredo Sardela. 2014. "Prevalence, Detectability, Analytical Implications, and Challenges." Substance Use and Misuse, doi:10.3109/10826084.2014.907653.

Comparing results from Brazil's accredited doping control laboratory with global statistics from the World Antidoping Agency reveals that Brazilian athletes dope with stimulants at above-average rates. Reasons include "self-administration," a "body shaping" culture, and the use of nutritional supplements.

Read more:

Carolina Dizioli Rodrigues de Oliveira, André Valle de Bairros, and Mauricio Yonamine. 2014. "Blood Doping: Risks to Athletes' Health and Strategies for Detection." Substance Use and Misuse, doi:10.3109/10826084.2014.903754.

This article reviews and discusses blood doping substances and methods used in sports, adverse effects related to this practice, and current strategies for its detection.

Read more:

Dongchun Wang. 2014. "Longer-Term Use of Opioids, Second Edition." Workers Compensation Research Institute. WC–14–19.

This 25-state study of 264,000 first workers' compensation claims for injury from October 2007 to September 2010 found they involved 1.5 million opioid prescriptions filled through March 2012. The data reflect an average of 24 months of experience. The study also examined how often the services recommended by medical treatment guidelines including drug testing and psychological evaluations and treatment were used for monitoring and managing chronic opioid therapy, but those findings are not accessible unless one purchases the study.

Read more:

Professional Education & Editorial

Kathleen Broglio and B. Eliot Cole. 2014. "Prescribing Opioids in Primary Care Avoiding Perils and Pitfalls." Nurse Practitioner, doi: 10.1097/01.NPR.0000446868.79458.da.

Millions of Americans have chronic pain for which chronic opioid therapy may be warranted. In light of recent problems with abuse of these medications, clinicians must exercise caution and develop uniform approaches to prescribing. It is possible to assess for opioid risk and safely prescribe opioids.

Read more:


New Mexico Department of Health: Progress Puts Prescription Drugs to Better Use
Las Cruces Sun–News
May 7, 2014

The New Mexico Department of Health and the New Mexico Board of Pharmacy reported that prescription opioids dispensed statewide decreased by 10 percent in 2013. One factor in the decline was mandated prescription monitoring program use. Department of Health Secretary Retta Ward said that small changes such as decreasing the quantity of medication prescribed also reduced opportunities for nonmedical use. Licensing boards also have increased required prescriber education on treatment of chronic pain. To reduce overdose deaths, the Health Department is working to make naloxone more available to patients with opioid prescriptions and their families.

Read more:

Police Access to Prescription-Drug Records Gets Tougher
Wall Street Journal
May 7, 2014

In 17 states, law-enforcement authorities must get court approval before searching prescription drug monitoring program (PDMP) databases. Privacy advocates, defense lawyers, and others think warrantless searches of these databases violate individuals' privacy rights. Despite rulings that patients have an expectation of privacy, few courts have ruled that police require a warrant to access PDMP records.

Read more:

Court Helps Veterans Who Become Addicts
Philly.com (Pennsylvania)
April 27, 2014

In 2008, Judge Robert T. Russell Jr. started the first Veterans Treatment Court in Buffalo, N.Y. Today, 131 of these courts exist nationwide. They combine biweekly court appearances with treatment for substance abuse and mental illness. Justin Slesser describes how Veterans Drug Court saved his life.

Read more:

Other State and Local News

Atty. Gen. Bondi Announces Funding for Prescription Drug Monitoring Program
Florida Office of the Attorney General
May 5, 2014

Atty. Gen. Pam Bondi will use $2 million from a past settlement with Caremark to fund the Florida prescription drug monitoring program for four years. Legislators did not pass a bill that included state funding for the program.

Read more:

Pennsylvania Senate Passes Prescription Drug Monitoring Program
May 7, 2014

The Pennsylvania Senate passed a bill that will create an improved prescription drug monitoring program. Both the House and Senate have now passed versions of this legislation that define how law enforcement would access the database. The American Civil Liberties Union said each version has different strengths, but because neither contains adequate privacy protections it cannot support the bill.

Read more:

Rhode Island Senate Approves Bills to Fight Drug Abuse, Overdose Deaths
Providence Journal
May 6, 2014

The Rhode Island Senate passed three bills intended to fight drug abuse and address the growing problem of drug overdose deaths. S–2801Aaa requires health insurers to "provide coverage for the treatment of mental health and substance use disorders under the same terms and conditions as that coverage is provided for other illnesses and diseases." It also requires healthcare facilities to provide information about addiction-treatment options to persons who present with a substance use disorder. At discharge, providers would inform abusers about outpatient and inpatient treatment services available at that moment and schedule a follow-up appointment. S–2523A requires medical professionals to register with the state's prescription drug monitoring program when they obtain or renew a controlled substances registration. S–2561 allows prescribers to transmit controlled-substances prescriptions to pharmacists by facsimile.

Read more:

Massachusetts Senate Unveils Bill to Combat Opioid Abuse
May 8, 2014

A Massachusetts Senate bill requires a commission to develop a list of drugs that can be substituted for opiates without abuse deterrent properties. Pharmacists would then be required to dispense the safer drugs, unless instructed otherwise by a doctor, and insurers would be required to cover those drugs in the same way they would cover traditional opiates. The bill would give the state's Commission of Public Health the ability to regulate opiates. It would mandate that doctors receive training on prescription drug monitoring program use and consult the PDMP when prescribing a controlled substance. The bill would also remove insurance barriers that hamper getting treatment for substance abuse and fund additional study of effective treatments for substance abuse.

Read more:

Report Details Long-Term Prescription Drug Use Among Oklahoma's Injured Workers
May 8, 2014

A Workers Compensation Research Institute reported that 10 percent of injured Oklahoma workers took opioid prescriptions on a long-term basis, but few were tested for drugs or received psychological evaluations and treatment. Oklahoma was one of nine states called out in the report for its high proportion of long-term opioid use. The WCRI report analyzed data from workers' compensation claims where a worker lost more than seven days of work following injury, did not have surgery, and filled a prescription paid for by workers' compensation. In Oklahoma, only 25 percent of long-term users were monitored with urine drug testing, only 5 percent had psychological evaluations, and only 3 percent had psychological treatment.

Read more:

Oklahoma Looks to Kentucky as Prescriptions Fall in States With Required 'Doctor Shopping'
May 5, 2014

Some Oklahoma lawmakers and the governor would like to emulate Kentucky's success in reducing doctor shopping. Kentucky made it mandatory for doctors to check prescription drug monitoring program data. Opioid prescription decreases during the next 12 months included hydrocodone, 10 percent; oxycodone, 12 percent; alprazolam, 13 percent; and all narcotics, 9 percent. Other Oklahoma officials argue that mandatory checks would be expensive and largely unnecessary. Under a tentative deal negotiated in recent days, physician groups agreed to accept mandatory checks for the most frequently abused narcotics.

Read more:

Missouri Likely to Remain the Only State Without Prescription Drug Database
May 9, 2014

This article and audio (4 minutes 22 seconds) discuss the ongoing debate in Missouri about creating a prescription drug monitoring program (PDMP). Concerns over privacy have stirred opposition. Missouri is the only state without a PDMP. Bills introduced in the House and Senate seem unlikely to pass. Ron Fitzwater, chief executive of the Missouri Pharmacy Association, said the Senate proposal was too weak to reduce abuse and favors a stronger system.

Read more:

Pols, First Responders Debate Letting Officers Give Overdose Antidote
Seacoast Media Group
May 6, 2014

New Hampshire officials are debating whether police officers should be allowed to administer Narcan. U.S. Sen. Kelly Ayotte announced that she is cosponsoring legislation that would exempt first responders from liability related to the administration of Narcan. David Lang, head of the statewide firefighters union, countered by criticizing Ayotte for not consulting with firefighters before including police officers in the Narcan discussion. Lang noted that the state Medical Control Board is poised to authorize an additional 2,500 licensed emergency medical first responders and basic emergency medical technicians to administer Narcan. Portsmouth Deputy Police Chief Corey MacDonald said his department supports allowing officers to carry and administer Narcan but believes the decision should be left to individual cities and towns.

Read more:

Gov. Corbett Addresses Opioid Issue
Office of the Governor, Pennsylvania
May 9, 2014

Pennsylvania Gov. Tom Corbett convened a group of local and state health, legislative, judicial, and law enforcement officials along with individuals affected by addiction to discuss the response to Pennsylvania's growing opioid addiction and overdose situation. The governor's plan is aimed at raising awareness about Pennsylvania's growing opioid problem and discussing how healthcare, law enforcement, and community groups can increase collaboration to stop the cycle of addiction and stem the growing opioid overdose problem statewide. Corbett announced he is directing Department of Drug and Alcohol Programs Secretary Gary Tennis to lead a working group of government officials to coordinate efforts at the state and local levels. They will hold panel discussions around the state to hear from afflicted communities and experts.

Read more:

Accidental Drug Fatalities Spike in Osceola, Orange, Fla.
Orlando Sentinel
May 9, 2014

The Florida Medical Examiner's Office reported that 166 people accidentally died from drug misuse in Orange and Osceola counties in 2013, a 7 percent increase from the previous year. The toll included 103 deaths from prescription drugs alone or in combination with illicit drugs.

Read more:

Channel 9 Investigates: Drug Rings Pushing Prescription Drugs in Your Neighborhood
May 7, 2014

North Carolina Bureau of Investigation Special Agent Donnie Varnell said more organized groups are popping up in North Carolina and profiting from the growing addiction problem. Fake prescriptions, mainly for oxycodone, are filled at local pharmacies by drug addicts. A month's supply of 30 pills is worth $900. (Editor's note: high-dose prescriptions often exceed 30 pills.) The dealers pay the addicts with pills. Channel 9 contacted the state's Department of Health and Human Services, which operates North Carolina's prescription drug database, to find out if it considered joining an interstate prescription data hub. A spokesperson said the agency is currently looking at two options.

Read more:

Oxycontin Smuggled Into Spokane, Wash., on Flights, Investigators Say
May 8, 2014

Federal investigators said that women with ties to a Los Angeles, Calif., gang smuggled about 10,000 illicit oxycodone pills a week through Spokane International Airport. The pills were sold by Spokane drug dealers, and the cash collected was then flown back to California. Local and federal drug agents busted the suspected ring in March 2013. Through wiretaps, luggage searches, and social media postings, investigators built a case that women were hiding drugs on their bodies, arriving with between 2,000 and 3,000 pills every two or three days. One male ringleader recently pleaded guilty in federal court. He was responsible for more than 2 million oxycodone pills arriving in Spokane.

Read more:

Adderall Abuse, a Growing Trend on College Campuses
May 5, 2014

This article and video (3 minutes, 56 seconds) discuss Adderall abuse among college students in Arkansas, Kansas, Missouri, and Oklahoma. It also discusses the health risks and personal consequences for using Adderall without a prescription. Experts strongly encourage anyone who thinks he or she suffers from ADHD to get tested by a doctor rather than attempting self-diagnosis.

Read more:

Christie Cites Death of Friend, Urges New Jersey Doctors to Be More Vigilant About Prescription Drug Abuse
May 2, 2014

New Jersey Gov. Chris Christie urged doctors to be more careful about their habits in prescribing drugs, and to use the state's prescription drug monitoring program. During the Medical Society's conference recently, Christie described how deeply affected he was by the recent death of a close friend addicted to pain medication. An estimated 20 percent to 25 percent of doctors in the state voluntarily use the program, and pharmacies are required to report prescribing information on a regular basis.

Read more:

Other Resources

Prescription Drug Abuse—It's Not What the Doctor Ordered
Digital Journal
May 6, 2014

This press release discusses the launch of the 2014 Media Awareness Campaign "Prescription Drug Abuse—It's Not What the Doctor Ordered," by the Georgia Prescription Drug Abuse Prevention Initiative of the Council on Alcohol and Drugs. The campaign concentrates on educating the community about how to prevent prescription drug abuse. The campaign's Web site includes links to downloadable resources. Nearly 5,000 radio public service announcements have aired or will air during morning and evening drive times in late April and May. The Awareness Campaign also includes a Facebook ad component that connects with social media users.

Read more:

New Online Community From Dr. Lynn Webster Helps Clients With Chronic Pain Management
May 5, 2014

This press release discusses Your Pain Community, an online community that helps its members avoid the dangers of prescription drug abuse. One resource it uses is the eight opioid safety principles for patients and caregivers. These safety principles are an excellent starting point to help patients and caregivers learn how best to protect themselves from the growing epidemic of prescription medication misuse.

Read more:

Treatment Research Institute. 2014. "Paving the Way to Change: Advancing Quality Intervention for Adolescents Who Use, Abuse, or Are Dependent on Alcohol or Other Drugs."

This resource provides insight into the individual, societal, and financial consequences of adolescent alcohol use, drug use, and other substance use disorders. It provides an overview of the current treatment system and an explanation of why it is failing our children. It also provides a new opportunity and a clearer lens for viewing and ultimately treating adolescents, as well as how to approach financing the system.

Read more:

Grant Announcement

Prescription Drug Overdose: Boost for State Prevention
Centers for Disease Control and Prevention
Deadline: June 4, 2014

Grant Awarded

$123,500 in Federal Funding Awarded for Harrison County (W.Va.) Drug Prevention
May 7, 2014

The Harrison County (W.Va.) Prevention Partnership won a $123,500 grant from the Substance Abuse and Mental Health Services Administration. The partnership will use the funding to strengthen its drug education and awareness program. Harrison County has the highest rate of prescription drug overdose in a 13-county region of West Virginia.

Read more:

Take-Back Events

Bucks County, Pa., Drug Take-Back Program Collects Nearly 38,000 Pounds
May 9, 2014

25 Tons of Drugs During April's National Prescription Drug 'Take Back'
Wisconsin Daily Independent
May 3, 2014

Ohioans Dispose of More Than 14 Tons of Unwanted Pills During National Prescription Drug Take-Back Day
Norwalk Reflector
May 3, 2014

PACE Coalition Purchases Prescription Drug Container for Police Department
Elko (Nev.) Daily Free Press
May 8, 2014

Bucks County (Pa.) Residents Turn in More Than 6,200 Pounds of Prescription Drugs
May 7, 2014

42 Pounds of Prescription Meds Collected
Jamestown (R.I.) Press
May 8, 2014

Durham–Middlefield, Conn., Clinic Nets 110 Pounds of Unused Prescription Drugs
Middletown Press
May 5, 2014

Pleasanton (Calif.) Police Collect 500 Pounds of Prescription Drugs on National Take-Back Day
Pleasanton Patch
May 3, 2014

Princeton (Minn.) Police Department, Pharmacies Install Drug Drop-Box
Princeton Union–Eagle
May 4, 2014

More Than 1,000 Pounds of Unwanted Medicine Collected in Northeast Tennessee
WCYB (Tennessee)
May 8, 2014

Collection Takes in Almost 6,500 Pounds of Drugs
WDEL (Delaware)
May 5, 2014

Save the Date

Sixth Annual American Medicine Chest Challenge National Day of Awareness and Safe Disposal of Prescription and Over-the-Counter Medicine
American Medicine Chest Challenge
November 8, 2014

Upcoming Conferences and Workshops

Prescription for Prevention: Preventing and Responding to Prescription Drug Abuse on Campus
Temple University, Villanova University, U.S. Attorneys' Office, and the Clery Center
June 11, 2014
Philadelphia, Pennsylvania

Pharmacy Diversion Awareness Conference
U.S. Department of Justice, Drug Enforcement Administration
June 28–29, 2014—Renaissance Phoenix (Ariz.) Downtown
July 12–13, 2014—Sheraton Philadelphia (Pa.) Downtown Hotel
August 2–3, 2014—Denver (Colo.) Marriott Tech Center

CADCA's Midyear Training Institute 2014
July 20–24, 2014
Orlando, Florida

Prevention of Youth Substance Abuse in Rural Communities Conference: Bringing Hope to Communities in Despair
Coalition for Healthy Youth
August 6–8, 2014
Lancaster, South Carolina

Preventing Prescription Drug Abuse—Nonmembers
New Jersey Pharmacists Association
August 7, 2014
6:00–8:30 p.m.
La Reggia Restaurant, 40 Wood Avenue, Secaucus, New Jersey

This presentation is designed to improve Pharmacists and Pharmacy Technicians' knowledge about the most commonly abused prescription drugs, including stimulants, depressants, and pain relievers. All participants will be exposed to best-practice suggestions and current state programs that are stemming the problem in New Jersey.

Twenty-Seventh Annual NPN Prevention Research Conference
National Prevention Network
September 15–18, 2014
Hartford, Connecticut

2014 Harold Rogers Prescription Drug Monitoring Program National Meeting
Brandeis University, Prescription Drug Monitoring Program Training and Technical Assistance Center
September 22–24, 2014
Washington, D.C.
The Weekly Update is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoint or opinion and are not assessed for validity, reliability or quality. The Weekly Update should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full text of journal articles listed in the Weekly Update.